AusPAR: Larotrectinib

Australian Public Assessment Report

AusPAR

AusPAR: Larotrectinib [PDF, 944.32 KB]

AusPAR: Larotrectinib [Word, 2.33 MB]

Attachment: Product Information for Larotrectinib [PDF, 305.85 KB]

Attachment: Product Information for Larotrectinib [Word, 153.05 KB]

Device/Product Name

Vitrakvi

Active ingredients

Larotrectinib

AusPAR Date

16 December 2020

Published

21 December 2020

Submission Number

PM-2019-02585-1-5

Submission Type

New chemical entity

Decision

Approved for provisional registration